Literature DB >> 29649444

Single HIV-1 Imaging Reveals Progression of Infection through CA-Dependent Steps of Docking at the Nuclear Pore, Uncoating, and Nuclear Transport.

Ashwanth C Francis1, Gregory B Melikyan2.   

Abstract

The HIV-1 core consists of capsid proteins (CA) surrounding viral genomic RNA. After virus-cell fusion, the core enters the cytoplasm and the capsid shell is lost through uncoating. CA loss precedes nuclear import and HIV integration into the host genome, but the timing and location of uncoating remain unclear. By visualizing single HIV-1 infection, we find that CA is required for core docking at the nuclear envelope (NE), whereas early uncoating in the cytoplasm promotes proteasomal degradation of viral complexes. Only docked cores exhibiting accelerated loss of CA at the NE enter the nucleus. Interestingly, a CA mutation (N74D) altering virus engagement of host factors involved in nuclear transport does not alter the uncoating site at the NE but reduces the nuclear penetration depth. Thus, CA protects HIV-1 complexes from degradation, mediates docking at the nuclear pore before uncoating, and determines the depth of nuclear penetration en route to integration.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV inhibitors; HIV uncoating; capsid protein; cyclophilin A; integration; nuclear import; nuclear pore; proteasomal degradation; reverse transcription; single-particle tracking

Mesh:

Substances:

Year:  2018        PMID: 29649444      PMCID: PMC5901770          DOI: 10.1016/j.chom.2018.03.009

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  48 in total

1.  The stoichiometry of Gag protein in HIV-1.

Authors:  John A G Briggs; Martha N Simon; Ingolf Gross; Hans-Georg Kräusslich; Stephen D Fuller; Volker M Vogt; Marc C Johnson
Journal:  Nat Struct Mol Biol       Date:  2004-06-20       Impact factor: 15.369

2.  Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection.

Authors:  Zandrea Ambrose; KyeongEun Lee; Jean Ndjomou; Hongzhan Xu; Ilker Oztop; James Matous; Taichiro Takemura; Derya Unutmaz; Alan Engelman; Stephen H Hughes; Vineet N KewalRamani
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants.

Authors:  Massimo Pizzato; Otto Erlwein; David Bonsall; Stephen Kaye; David Muir; Myra O McClure
Journal:  J Virol Methods       Date:  2008-12-05       Impact factor: 2.014

4.  Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1.

Authors:  O Schwartz; V Maréchal; B Friguet; F Arenzana-Seisdedos; J M Heard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Second generation imaging of nuclear/cytoplasmic HIV-1 complexes.

Authors:  Ashwanth Christopher Francis; Cristina Di Primio; Valentina Quercioli; Paola Valentini; Annegret Boll; Gabriele Girelli; Francesca Demichelis; Daniele Arosio; Anna Cereseto
Journal:  AIDS Res Hum Retroviruses       Date:  2014-06-06       Impact factor: 2.205

6.  Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication.

Authors:  Brett M Forshey; Uta von Schwedler; Wesley I Sundquist; Christopher Aiken
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes.

Authors:  M Simm; M Shahabuddin; W Chao; J S Allan; D J Volsky
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components.

Authors:  Martha R Neagu; Patrick Ziegler; Thomas Pertel; Caterina Strambio-De-Castillia; Christian Grütter; Gladys Martinetti; Luca Mazzucchelli; Markus Grütter; Markus G Manz; Jeremy Luban
Journal:  J Clin Invest       Date:  2009-09-08       Impact factor: 14.808

9.  Single-cell imaging of HIV-1 provirus (SCIP).

Authors:  Cristina Di Primio; Valentina Quercioli; Awatef Allouch; Rik Gijsbers; Frauke Christ; Zeger Debyser; Daniele Arosio; Anna Cereseto
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-19       Impact factor: 11.205

10.  Dynamics and regulation of nuclear import and nuclear movements of HIV-1 complexes.

Authors:  Ryan C Burdick; Krista A Delviks-Frankenberry; Jianbo Chen; Sanath K Janaka; Jaya Sastri; Wei-Shau Hu; Vinay K Pathak
Journal:  PLoS Pathog       Date:  2017-08-21       Impact factor: 6.823

View more
  79 in total

1.  Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action.

Authors:  Jimmy P Xu; Ashwanth C Francis; Megan E Meuser; Marie Mankowski; Roger G Ptak; Adel A Rashad; Gregory B Melikyan; Simon Cocklin
Journal:  J Drug Des Res       Date:  2018-08-13

2.  A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.

Authors:  Mohammad Adnan Siddiqui; Akatsuki Saito; Upul D Halambage; Damien Ferhadian; Douglas K Fischer; Ashwanth C Francis; Gregory B Melikyan; Zandrea Ambrose; Christopher Aiken; Masahiro Yamashita
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

3.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

4.  Capsid-CPSF6 interaction: Master regulator of nuclear HIV-1 positioning and integration.

Authors:  Vasudevan Achuthan; Jill M Perreira; Jenny J Ahn; Abraham L Brass; Alan N Engelman
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

5.  HIV-1 capsids mimic a microtubule regulator to coordinate early stages of infection.

Authors:  Eveline Santos da Silva; Shanmugapriya Shanmugapriya; Viacheslav Malikov; Feng Gu; M Keegan Delaney; Mojgan H Naghavi
Journal:  EMBO J       Date:  2020-09-08       Impact factor: 11.598

6.  Design of reverse transcriptase-specific nucleosides to visualize early steps of HIV-1 replication by click labeling.

Authors:  Flore De Wit; Sambasiva Rao Pillalamarri; Alba Sebastián-Martín; Akkaladevi Venkatesham; Arthur Van Aerschot; Zeger Debyser
Journal:  J Biol Chem       Date:  2019-06-14       Impact factor: 5.157

7.  Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.

Authors:  Augustin Penda Twizerimana; Rachel Scheck; Daniel Becker; Zeli Zhang; Marianne Wammers; Leandro Avelar; Marc Pflieger; Dieter Häussinger; Thomas Kurz; Holger Gohlke; Carsten Münk
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

8.  Modular HIV-1 Capsid Assemblies Reveal Diverse Host-Capsid Recognition Mechanisms.

Authors:  Brady J Summers; Katherine M Digianantonio; Sarah S Smaga; Pei-Tzu Huang; Kaifeng Zhou; Eva E Gerber; Wei Wang; Yong Xiong
Journal:  Cell Host Microbe       Date:  2019-08-14       Impact factor: 21.023

Review 9.  Exploitation of Cytoskeletal Networks during Early Viral Infection.

Authors:  Derek Walsh; Mojgan H Naghavi
Journal:  Trends Microbiol       Date:  2018-07-20       Impact factor: 17.079

10.  Capsid Lattice Destabilization Leads to Premature Loss of the Viral Genome and Integrase Enzyme during HIV-1 Infection.

Authors:  Jenna E Eschbach; Jennifer L Elliott; Wen Li; Kaneil K Zadrozny; Keanu Davis; Shawn J Mohammed; Dana Q Lawson; Owen Pornillos; Alan N Engelman; Sebla B Kutluay
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.